Lutetium-(177Lu)-oxodotreotide: Anaemia.
In: Reactions Weekly, Jg. 1986 (2023-12-09), Heft 1, S. 248-248
serialPeriodical
Zugriff:
A study was conducted to evaluate the effects of lutetium-(177Lu)-oxodotreotide on gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The study included 95 patients, and one patient experienced grade 3 anemia during treatment with cyclical lutetium-(177Lu)-oxodotreotide. The article does not provide specific details about the patient's age, sex, route of administration, dosage, duration of treatment, or outcome. [Extracted from the article]
Copyright of Reactions Weekly is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Lutetium-(177Lu)-oxodotreotide: Anaemia.
|
---|---|
Zeitschrift: | Reactions Weekly, Jg. 1986 (2023-12-09), Heft 1, S. 248-248 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 0114-9954 (print) |
DOI: | 10.1007/s40278-023-51553-0 |
Schlagwort: |
|
Sonstiges: |
|